Eli Lilly said on Thursday its experimental pill, orforglipron, led to a weight loss of nearly 8% at the highest dose and lowered blood sugar for overweight patients with Type 2 diabetes in a late-stage trial. Shares of the company jumped nearly 13% in premarket… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]
Published on April 17, 2025
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. The Advisory Committee on Immunization Practices also voted to recommend a shot to protect… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on April 16, 2025
Step tracking with mindfulness training delivered via a mobile app boosts people’s desire to exercise. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a […]
Published on April 16, 2025